Inventor · disambiguated record
Vanessa Gauttier
Also filed as: GAUTTIER VANESSA
7 granted patents·11 pending applications·5 citations·filing 2016–2025
75Inventor score
Top patents by PatentIndex Score
18 records- 0187US11279766B2Anti-SIRPa antibodies and their therapeutic applicationsOSE IMMUNOTHERAPEUTICS·Filed 2017·Granted Mar 22, 2022·3 cites·47 claims
- 0281US2024279352A1Methods and compositions for modifying macrophage polarization into pro-inflammatory cells to treat cancerOSE IMMUNOTHERAPEUTICS·Filed 2024·Application pending·0 cites
- 0380US11365257B2Methods for promoting t cells response by administering an antagonist of human c-type lectin-like receptor 1 (CLEC-1)INST NAT SANTE RECH MED·Filed 2017·Granted Jun 21, 2022·2 cites·10 claims
- 0479US2024400695A1Methods for promoting t cells responseINST NAT SANTE RECH MED·Filed 2024·Application pending·0 cites
- 0576US12252546B2Anti-SIRPa antibodies and their therapeutic applicationsOSE IMMUNOTHERAPEUTICS·Filed 2022·Granted Mar 18, 2025·0 cites·23 claims
- 0675US12091464B2Method of promoting a t-cell response or treating cancer by administering an antagonist to human c-type lectin-like receptor-1 (CLEC-1)INST NAT SANTE RECH MED·Filed 2022·Granted Sep 17, 2024·0 cites·9 claims
- 0774US2025215108A1ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONSOSE IMMUNOTHERAPEUTICS·Filed 2025·Application pending·0 cites
- 0871US2022298259A1Methods and compositions for modifying macrophage polarization into pro-inflammatory cells to treat cancerOSE IMMUNOTHERAPEUTICS·Filed 2022·Application pending·0 cites
- 0970US2024400698A1Anti-chemokin like receptor 1 antibodies and their therapeutic applicationsOSE IMMUNOTHERAPEUTICS·Filed 2024·Application pending·0 cites
- 1069US12331115B2Uses of anti-SIRPg antibodiesOSE IMMUNOTHERAPEUTICS·Filed 2022·Granted Jun 17, 2025·0 cites·3 claims
- 1157US2025026839A1Identification of CLEC-1 Ligand and Uses ThereofOSE IMMUNOTHERAPEUTICS·Filed 2022·Application pending·0 cites
- 1255US12448454B2Humanized anti-CLEC-1A antibodies and antigen-binding fragments thereofOSE IMMUNOTHERAPEUTICS·Filed 2022·Granted Oct 21, 2025·0 cites·18 claims
- 1354US2018312600A1Methods and compositions for modifying macrophage polarization into pro-inflammatory cells to treat cancerOSE IMMUNOTHERAPEUTICS·Filed 2016·Application pending·0 cites
- 1452US2021147558A1Anti-chemokin like receptor 1 antibodies and their therapeutic applicationsOSE IMMUNOTHERAPEUTICS·Filed 2019·Application pending·0 cites
- 1550US2023181721A1Vaccine against sars-cov virusOSE IMMUNOTHERAPEUTICS·Filed 2021·Application pending·0 cites
- 1650US2023331852A1Anti-clec-1a antibodies and antigen-binding fragment thereofOSE IMMUNOTHERAPEUTICS·Filed 2020·Application pending·0 cites
- 1747US11884723B2Use of anti-human SIRPa v1 antibodies and method for producing anti-SIRPa v1 antibodiesOSE IMMUNOTHERAPEUTICS·Filed 2019·Granted Jan 30, 2024·0 cites·20 claims
- 1847US2019382483A1NEW USES OF ANTI-SIRPg ANTIBODIESOSE IMMUNOTHERAPEUTICS·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vanessa Gauttier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →